Fig. 3From: Development and clinical validation of a novel six-gene signature for accurately predicting the recurrence risk of patients with stage II/III colorectal cancerKaplan–Meier survival analysis of CRRS in four cohorts. Kaplan–Meier curves of RFS according to the CRRS in GSE143985 (A), GSE17536 (B), GSE29621 (C), and GSE92921 (D)Back to article page